Full-Time

Commercial Learning Manager

Posted on 8/27/2025

Intuitive Surgical

Intuitive Surgical

10,001+ employees

Manufactures robotic surgical systems and services

No salary listed

Bengaluru, Karnataka, India

In Person

Category
Training
Required Skills
Sales
Requirements
  • Core key competencies: Take Initiative, Effective Communicator, Confident Presenter, Flexibility, Team Player, Innovative, acts as a Coach/Mentor, Strong Product/Service Knowledge, and Establishes Presence
  • Establishes executive presence
  • Ambition and strong work ethic
  • Ability to excel in a high-energy, fast-paced environment
  • Ability to organize and work under strict time deadlines, while producing quality deliverables
  • Proven ability to work effectively as part of a team
  • Strong organizational and prioritization skills
  • Excellent presentation, oral, and written communication skills
  • Proficiency in MS office
  • Bachelor’s degree or equivalent experience required
  • Master’s Degree or equivalent training experience a plus
  • 5+ years of Sales and/or Sales Management experience, preferably in the medical device field
  • 2+ years of Corporate Training, Field Training with Corporate responsibility or Training Management experience
Responsibilities
  • Manage projects and training initiatives as assigned by Senior Manager, Commercial Learning
  • Partner with the Commercial Management Team to support the sales strategy by aligning all training programs and initiatives to the priorities
  • Assess sales team’s strengths and gaps pertaining to knowledge and skills; Develop programs to address competency gaps
  • Collaborate with internal partners within Global Commercial Learning, Salesforce Effectiveness, ISI Business School, HR, Talent Development, Clinical Product Education and other cross functional partners to standardize business processes
  • Manage new product commercialization initiatives to create training curricula, collaborate with cross-functional teams to roll out training and lead train-the-trainer sessions as needed
  • Teach trainers relevant Standard Operating Procedures and training processes
  • Mentor and Coach Commercial Learning Trainer and Commercial Learning Sr. Trainer on training best practices and processes
  • Become a Subject Matter Expert of da Vinci® Surgical System pre, intra and postoperative management
  • Maintain “expert” level certification of da Vinci® Surgical Systems, da Vinci® Instruments and Accessories, and da Vinci® Advanced Technology
  • Educate Intuitive Commercial employees to train and support their da Vinci® customers on: da Vinci® Instruments and Accessories, da Vinci® Advanced Technology, da Vinci® 5, da Vinci® Xi, da Vinci® X, and da Vinci® SP Surgical Systems
  • Educate Intuitive Commercial employees on the da Vinci® technical value propositions
  • Lead Train-the-Trainer Technical programs and training for Global Commercial Learning peers
  • Assess training participants technical competency
  • Become a Subject Matter Expert across key specialties: general surgery, colorectal surgery, gynecologic surgery, thoracic surgery, urology and Cardiac
  • Maintain “expert” level certification of da Vinci surgical procedure lectures
  • Educate Intuitive Commercial employees on relevant clinical procedures as part of sales training programs and initiatives
  • Educate Intuitive Commercial employees on the da Vinci® clinical value propositions
  • Lead Train-the-Trainer Clinical programs and training for Global Commercial Learning peers
  • Assess training participants clinical competency
  • Effectively present and deliver ISI Clinical Sales Process and Capital Sales Process presentations and workshops to new and existing employees
  • Leverage various formats and venues for training programs, such as instructor-led, self-led, distance learning/remote, video and podcast, etc. to maximize the impact of the content
  • Assess training participants sales competency
  • Conduct routine field rides with field sales to diagnose common training needs as well as provide coaching, feedback and mentorship
  • Collaborate with cross-functional groups to create best in class sales training initiatives aligned with regional strategy
  • Facilitate hands on learning experiences to accelerate the commercial organizations proficiency on da Vinci technology
  • Manage all segments of new hire training programs: Clinical and System Training (CAST)
  • Create curricula, agendas and training materials for all technical, clinical and sales training programs for existing commercial employees
  • Proctor training evaluations
  • Collaborate with Learning & Technology Specialist to execute e-learning initiatives
  • Identify resource needs with Systems and Logistics Coordinator
  • Measure sales effectiveness of training programs and develop reports and comprehensive programs analysis
Desired Qualifications
  • Master’s Degree or equivalent training experience a plus

Intuitive Surgical designs, manufactures, and sells robotic surgical systems and provides related services and accessories for minimally invasive surgery. The core product helps surgeons perform operations with enhanced precision by guiding robotic arms controlled from a console, allowing procedures to be done through small incisions. Instruments and consumables are used with the systems and are supported by service contracts, creating a recurring revenue stream. Compared to competitors, Intuitive has a large installed base and focuses specifically on robotic-assisted surgery, combining devices, disposable instruments, and ongoing services to support hospitals and surgical centers. Its goal is to improve patient outcomes by enabling safer, less invasive procedures while expanding the use and capabilities of robotic surgery for more procedures and providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Simplify Jobs

Simplify's Take

What believers are saying

  • Bariatric surgery market expansion as da Vinci outperforms GLP-1 drugs for sustained weight loss.
  • Ion bronchoscopy system procedures grew 39% YoY with 1,041 installed units capturing lung cancer detection.
  • Less than 5% of eligible surgeries globally performed robotically indicates substantial international adoption runway.

What critics are saying

  • FDA Class II recalls of instruments with fraying cables disrupt 86% of Q1 recurring revenue.
  • FDA safety communication on curved tip staplers halts hospital use, eroding surgeon confidence in reliability.
  • EU MDR recertification deadline December 2028 halts 25% European sales during redesign and testing.

What makes Intuitive Surgical unique

  • 70-80% market share in soft-tissue robotics with 11,395 installed da Vinci systems globally.
  • 85% recurring revenue from instruments, accessories, and service contracts provides predictable cash flow.
  • da Vinci 5 platform expands into cardiac surgery and complex procedures previously requiring open surgery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Apr 7th, 2026
Intuitive Surgical emerges as dark horse in anti-obesity market as surgery outperforms GLP-1 drugs

Intuitive Surgical could emerge as a dark horse in the anti-obesity market as bariatric surgery proves more effective than GLP-1 drugs for long-term weight loss. A recent study of over 50,000 patients found surgery patients lost an average of 58 pounds after two years, compared to just 12 pounds for those using GLP-1 medications. The study also showed surgery delivers more sustainable results. Gastric bypass patients maintain around 52% of their excess weight loss after 10 years, whilst GLP-1 users often regain all lost weight after stopping treatment. Intuitive's da Vinci surgical system offers minimally invasive bariatric surgery options. The company generated $10.1 billion in revenue last year, up from $8.4 billion, with profit margins around 28%. Despite shares falling over 20% this year, the company's position in surgical innovation makes it a compelling long-term investment.

Yahoo Finance
Mar 29th, 2026
Intuitive Surgical shares drop 19% YTD, but analysts see 15% upside potential

Intuitive Surgical has experienced recent share price weakness, declining 3% in one day with negative returns over the past week, month and three months. The stock currently trades at $452.66, down 10.1% over one month and 19.45% year-to-date, though three-year total shareholder returns remain strong at 77.19%. The medical technology company reports annual revenue of $10.1 billion and net income of $2.9 billion, maintaining a dominant position in minimally invasive surgical technology. According to one valuation analysis, Intuitive Surgical's fair value sits at $532.46, suggesting the stock is undervalued by approximately 15% at current levels. The analysis projects 12% annual revenue growth over the next five years, supported by recurring revenues from spare parts and software licences, with profit margins expected to reach 30% from the current 28.6%.

Yahoo Finance
Mar 28th, 2026
Intuitive Surgical shares up 23% after Jim Cramer's buy recommendation

Intuitive Surgical shares rose 23% following Jim Cramer's recommendation on CNBC's Squawk on the Street in June 2025, where he urged investors to "just go buy ISRG". The medical robotics company experienced a 27% surge in October after reporting third-quarter earnings that beat analyst estimates. Revenue reached $2.51 billion against expectations of $2.40 billion, whilst adjusted earnings per share hit $2.40 versus the predicted $1.98. However, the stock declined 2.7% in January 2026 after Intuitive Surgical released preliminary fourth-quarter results, citing concerns that Medicaid funding cuts and competing products could slow growth of its robotic surgical systems. Despite the recent setback, shares remain up significantly since Cramer's initial endorsement, though they're down 7.8% over the past year.

Yahoo Finance
Mar 28th, 2026
Intuitive Surgical faces tariff headwinds and rising competition despite 19% revenue growth to $2.87B

Intuitive Surgical faces headwinds from tariffs and increased competition in the robotic-assisted surgery market, yet its fundamentals remain strong. The medical device company reported fourth-quarter revenue growth of 19% to $2.87 billion, whilst adjusted earnings per share rose 14.5% to $2.53. Procedures using its da Vinci surgical system increased 17%, with the installed base growing 12% to 11,106 units. However, the stock trades at 47.6 times forward earnings, compared to the healthcare sector average of 17.1. New competition is emerging, with Medtronic's Hugo system recently cleared and Johnson & Johnson expected to launch its own device soon. Despite these challenges, Intuitive Surgical maintains advantages through switching costs and extensive real-world data, whilst the underpenetrated robotic-assisted surgery market offers long-term growth potential.

Yahoo Finance
Mar 24th, 2026
ISRG maintains 37% operating margins in Q4 despite 95 bps tariff drag

Intuitive Surgical maintained a 37% operating margin in Q4 despite tariffs creating a 95 basis point drag, alongside higher facility costs and unfavourable product mix from newer platforms like da Vinci 5 and Ion. The company offset these pressures through product cost reductions, component savings and manufacturing efficiencies. Procedure growth of 18% in Q4 and recurring revenue now comprising 81% of total revenues provided operating leverage. Management's 2026 gross margin guidance of 67-68% suggests continued stability, even as tariff headwinds are expected to increase to roughly 1.2% of revenues. Meanwhile, Boston Scientific expanded adjusted operating margins by 100 basis points to 28% in 2025, though tariffs will offset favourable product mix in 2026. The company expects 50-75 basis points operating margin expansion in 2026 through scale efficiencies and supply-chain optimisation.

INACTIVE